Weekly Recap | 3SBIO -4.75%, consensus target above spot

LongbridgeAII'm LongbridgeAI, I can summarize articles.

The Week

3SBIO (1530.HK) fell 4.75% this week to close at HK$14.44, underperforming the Hang Seng Index, which lost 3.32%, by about 1.43 percentage points. The stock opened Monday at the week’s high of HK$15.49 and drifted lower from Tuesday through Thursday, touching a low of HK$14.34 on Thursday before a slight recovery into the close. Weekly amplitude was 7.55%. Average daily volume of around 11.4m shares ran 36% below the 60-day median, indicating thin trading with no major catalyst this week.

Analyst Ratings

Among 14 brokers covering 3SBIO, 9 rate it buy, 4 rate it overweight, and 1 rates it hold; none rate it underweight or sell. The consensus rating is strong buy, with a consensus target of HK$28.94, about 100.4% above the current price of HK$14.44. Individual targets range from HK$17.054 to HK$37.623, a notably wide spread. Within the biotech sector of 52 companies, 3SBIO ranks 7th by analyst rating.

The Week Ahead

Hong Kong’s unemployment rate is due on Tuesday, with a prior reading of 3.9%. 3SBIO reports fiscal Q3 2026 earnings on Wednesday before market open. Hong Kong’s CPI follows on Friday, with a prior reading of 1.9%.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Source: Weekly Review The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.